Skip to content

TCM wisdom of non-alcoholic fatty liver disease based on objectification of tongue diagnosis Study on syndrome differentiation and individualized management

TCM wisdom of non-alcoholic fatty liver disease based on objectification of tongue diagnosis Study on syndrome differentiation and individualized management

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001433
Enrollment
Unknown
Registered
2026-06-05
Start date
2024-06-26
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver disease

Interventions

Observation group:Formulate individualized TCM syndrome differentiation guidance scheme
NAFLD research group:no
Control group:Carry out health behavior education

Sponsors

Chengdu Public Health Clinical Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who met the diagnostic criteria of NAFLD by western medicine; 2. Age of 18-75 years old both sexes; 3. The person who signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Combined with other malignant tumors; 2. Important organ dysfunction or significant systemic diseases; 3. Mentally ill or unable to cooperate with the examiner; 4. Women who are pregnant or planning to become pregnant; 5. Missing important clinical data; 6. Patients with moss caused by ingestion of certain foods or drugs.

Design outcomes

Primary

MeasureTime frame
CAP(Controlled Attenuation Parameter);LSM(Liver Stiffness Measurement);

Secondary

MeasureTime frame
HDL-C(High-Density Lipoprotein Cholesterol);AST(Aspartate Aminotransferase);TBIL(Total Bilirubin);LYM(Lymphocyte);HGB(Hemoglobin);IBIL(Indirect Bilirubin);NEU(Neutrophil;ALT(Alanine Aminotransferase);WBC(White Blood Cell Count);RBC(Red Blood Cell Count);CHOL(Total Cholesterol);TG(Triglyceride);LDL-C(Low-Density Lipoprotein Cholesterol);DBIL(Direct Bilirubin);PLT(Platelet Count);ALB(Albumin);

Countries

China

Contacts

Public ContactHuang Liang

Chengdu Public Health Clinical Medical Center

15201920@qq.com18981958276

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 29, 2026